NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.6700
Dollar change
0.0000
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.88 Insider Own27.88% Shs Outstand42.71M Perf Week-2.22%
Market Cap29.79M Forward P/E- EPS next Y-0.49 Insider Trans0.00% Shs Float32.07M Perf Month-4.29%
Enterprise Value32.08M PEG- EPS next Q-0.20 Inst Own16.61% Short Float9.23% Perf Quarter7.54%
Income-37.14M P/S1.06 EPS this Y-15.16% Inst Trans8.35% Short Ratio14.45 Perf Half Y-4.27%
Sales28.03M P/B0.39 EPS next Y29.54% ROA-25.58% Short Interest2.96M Perf YTD-14.77%
Book/sh1.73 P/C1.06 EPS next 5Y-23.53% ROE-42.58% 52W High1.55 -56.77% Perf Year-39.09%
Cash/sh0.63 P/FCF- EPS past 3/5Y49.44% 41.84% ROIC-39.83% 52W Low0.50 33.71% Perf 3Y-87.14%
Dividend Est.- EV/EBITDA- Sales past 3/5Y9.65% 29.04% Gross Margin52.50% Volatility5.63% 5.62% Perf 5Y-89.69%
Dividend TTM- EV/Sales1.14 EPS Y/Y TTM48.56% Oper. Margin-175.37% ATR (14)0.04 Perf 10Y-99.45%
Dividend Ex-Date- Quick Ratio1.77 Sales Y/Y TTM47.21% Profit Margin-132.49% RSI (14)44.43 Recom1.50
Dividend Gr. 3/5Y- - Current Ratio2.01 EPS Q/Q-47.86% SMA20-3.65% Beta1.56 Target Price2.38
Payout- Debt/Eq0.41 Sales Q/Q17.26% SMA50-5.81% Rel Volume0.42 Prev Close0.67
Employees202 LT Debt/Eq0.27 EarningsMay 14 BMO SMA200-12.92% Avg Volume204.87K Price0.67
IPOApr 09, 2013 Option/ShortYes / Yes EPS/Sales Surpr.-40.00% -9.67% Trades Volume85,298 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jan-29-25Downgrade TD Cowen Buy → Hold $2 → $1
May-13-22Upgrade Alliance Global Partners Neutral → Buy $8.75
Apr-22-21Initiated Cowen Outperform $31
Mar-23-21Initiated Stifel Buy $30
Feb-25-21Initiated Cantor Fitzgerald Overweight $35
Feb-01-21Downgrade Alliance Global Partners Buy → Neutral $15.60 → $22.25
Aug-17-20Initiated Aegis Capital Buy $25
Aug-29-17Initiated Aegis Capital Buy $3.50
May-09-16Initiated Rodman & Renshaw Buy $12
Jun-26-25 08:30AM
Jun-24-25 08:30AM
May-15-25 03:11AM
May-14-25 07:40AM
06:30AM
08:30AM Loading…
May-08-25 08:30AM
May-07-25 05:50PM
08:30AM
May-01-25 08:30AM
Apr-21-25 08:30AM
Apr-17-25 08:30AM
Apr-08-25 08:30AM
Mar-24-25 12:00PM
10:59AM
Mar-17-25 08:30AM
08:30AM Loading…
08:30AM
Mar-11-25 03:01AM
Mar-10-25 09:43AM
06:30AM
Mar-07-25 08:30AM
Mar-05-25 08:30AM
Mar-04-25 08:30AM
Feb-27-25 08:30AM
Feb-08-25 02:39AM
Feb-07-25 08:08AM
Jan-30-25 08:45AM
Jan-21-25 08:30AM
Jan-17-25 01:14PM
Jan-14-25 12:09PM
08:30AM
08:30AM Loading…
Nov-21-24 08:30AM
Nov-08-24 06:02AM
Nov-07-24 07:40AM
06:30AM
Nov-04-24 08:30AM
Oct-30-24 08:30AM
Oct-23-24 08:30AM
Oct-17-24 08:30AM
Oct-15-24 08:30AM
Oct-09-24 05:35PM
Oct-08-24 09:09AM
Oct-02-24 12:00PM
Oct-01-24 08:30AM
Sep-12-24 08:30AM
Sep-10-24 08:30AM
Aug-08-24 07:45AM
06:30AM
Jul-30-24 08:30AM
Jul-16-24 08:30AM
Jun-25-24 08:30AM
06:00AM
Jun-05-24 08:30AM
May-16-24 08:18AM
03:02AM
May-15-24 10:52AM
07:35AM
06:30AM
May-07-24 08:30AM
Apr-25-24 08:30AM
Apr-18-24 08:30AM
Apr-10-24 08:30AM
Apr-02-24 08:30AM
Apr-01-24 03:43PM
Mar-28-24 10:53AM
06:30AM
Mar-24-24 10:59AM
Mar-21-24 08:30AM
Mar-12-24 08:30AM
Feb-28-24 08:30AM
Feb-22-24 07:09AM
Feb-21-24 07:00AM
06:00AM
Jan-22-24 04:15PM
08:00AM
Jan-11-24 08:30AM
Dec-05-23 08:30AM
Nov-29-23 11:00AM
Nov-27-23 08:30AM
Nov-21-23 08:30AM
Nov-13-23 08:30AM
Nov-02-23 06:30AM
Nov-01-23 08:30AM
Oct-30-23 08:30AM
Oct-17-23 08:30AM
Oct-05-23 08:30AM
Oct-03-23 08:30AM
Sep-27-23 08:30AM
Aug-24-23 08:30AM
Aug-15-23 08:30AM
Aug-12-23 08:01AM
Aug-11-23 06:03AM
Aug-10-23 06:30AM
Aug-08-23 08:30AM
Aug-04-23 08:16AM
Aug-03-23 08:45AM
Aug-02-23 08:30AM
Jul-26-23 08:30AM
Jul-24-23 08:30AM
Jul-06-23 08:30AM
Jun-26-23 08:30AM
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nelson Steven CharlesChief Commercial OfficerNov 12 '24Buy0.915,0004,54655,000Nov 14 04:15 PM
Nelson Steven CharlesChief Commercial OfficerSep 10 '24Buy0.845,0004,22145,000Sep 12 04:37 PM
Nelson Steven CharlesChief Commercial OfficerSep 11 '24Buy0.805,0004,02250,000Sep 12 04:37 PM
Nelson Steven CharlesChief Commercial OfficerSep 06 '24Buy0.845,0004,20035,000Sep 10 06:00 AM
Nelson Steven CharlesChief Commercial OfficerSep 05 '24Buy0.825,0004,09130,000Sep 10 06:00 AM
Nelson Steven CharlesChief Commercial OfficerSep 09 '24Buy0.805,0004,00040,000Sep 10 06:00 AM
Raphael ErezChief Executive OfficerAug 27 '24Buy0.885,0004,4001,937,059Aug 28 06:12 PM
Nelson Steven CharlesChief Commercial OfficerAug 23 '24Buy0.955,0004,75025,000Aug 23 04:05 PM
Nelson Steven CharlesChief Commercial OfficerAug 22 '24Buy0.945,0004,72520,000Aug 23 04:05 PM
Nelson Steven CharlesChief Commercial OfficerAug 21 '24Buy0.935,0004,67215,000Aug 23 04:05 PM
Raphael ErezChief Executive OfficerAug 21 '24Buy0.955,0004,7501,932,059Aug 23 04:05 PM
Raphael ErezChief Executive OfficerAug 20 '24Buy0.935,0004,6501,927,059Aug 23 04:05 PM
Nelson Steven CharlesChief Commercial OfficerAug 20 '24Buy0.945,0004,68410,000Aug 20 04:01 PM
Nelson Steven CharlesChief Commercial OfficerAug 19 '24Buy0.925,0004,5985,000Aug 20 04:01 PM
Raphael ErezChief Executive OfficerAug 19 '24Buy0.905,0004,5001,922,059Aug 20 04:01 PM
Raphael ErezChief Executive OfficerAug 16 '24Buy0.905,0004,4801,917,059Aug 20 04:01 PM